Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | ADH1B | P00325 | 1/20 | 0.36 |
| ▸ | ADH1C | P00326 | 1/20 | 0.36 |
| ▸ | ADH1A | P07327 | 1/20 | 0.36 |
| ▸ | ADH4 | P08319 | 1/20 | 0.36 |
| ▸ | ADH7 | P40394 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24919619 | 0.91 | SIGMAR1 (0.36) | SIGMAR1ADH1BADH1CADH1AADH4 | |
| SCHEMBL8231944 | 0.89 | CYP2D6 (0.36) | SIGMAR1ADH1BADH1CADH1AADH4 | |
| SCHEMBL919776 | 0.88 | — | — | |
| SCHEMBL21948699 | 0.87 | SIGMAR1 (0.47) | SIGMAR1MAPT | |
| SCHEMBL20630194 | 0.87 | SIGMAR1 (0.34) | SIGMAR1MEN1KMT2AHTR2C | |
| Hydrochloric Acid SCHEMBL19556312 | 0.86 | — | — | |
| SCHEMBL20340832 | 0.85 | SIGMAR1 (0.36) | SIGMAR1ADH1BADH1CADH1AADH4 | |
| SCHEMBL8366602 | 0.85 | SIGMAR1 (0.33) | SIGMAR1 | |
| SCHEMBL23231226 | 0.84 | SIGMAR1 (0.35) | SIGMAR1ADH1BADH1CADH1AADH4 | |
| SCHEMBL25031323 | 0.84 | SIGMAR1 (0.35) | SIGMAR1ADH1BADH1CADH1AADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113461543-B | Rectification and purification method of 1, 3-cyclohexanediamine crude product | 万华化学集团股份有限公司 | 2024-02-02 | — | — | CN | disclosed |
| WO-2023149394-A1 | POLYMER, COMPOSITION, CURED PRODUCT, LAMINATED BODY, AND ELECTRONIC COMPONENT | JSR株式会社 | 2023-08-10 | — | — | WO | disclosed |
| US-11256002-B2 | Ophthalmic devices comprising photochromic materials with reactive substituents | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2022-02-22 | — | — | US | disclosed |
| WO-2020148190-A1 | HYDROXYURETHANE (METH)ACRYLATE PREPOLYMERS FOR USE IN 3D PRINTING | BASF SE (DE) | 2020-07-23 | — | — | WO | disclosed |
| EP-3680274-A1 | HYDROXYURETHANE (METH)ACRYLATE PREPOLYMERS FOR USE IN 3D PRINTING | BASF SE (DE) | 2020-07-15 | — | — | EP | disclosed |
| US-20190129067-A1 | OPHTHALMIC DEVICES COMPRISING PHOTOCHROMIC MATERIALS WITH REACTIVE SUBSTITUENTS | JOHNSON & JOHNSON VISION CARE (US) | 2019-05-02 | — | — | US | disclosed |
| EP-3278787-A1 | POLYMERIZABLE MONOMER FOR DENTAL MATERIALS, COMPOSITION, ADHESIVE DENTAL MATERIAL, AND KIT | Mitsui Chemicals, Inc. (JP) | 2018-02-07 | — | — | EP | disclosed |
| US-8500265-B2 | Ink jet ink, ink set, ink jet recording method, ink cartridge, recording unit and ink jet recording apparatus | CANON KABUSHIKI KAISHA (JP) | 2013-08-06 | — | — | US | disclosed |
| US-8123846-B2 | Ink jet ink, ink jet recording method, ink cartridge, recording unit and ink jet recording apparatus | CANON KABUSHIKI KAISHA (JP) | 2012-02-28 | — | — | US | disclosed |
| US-20090274840-A1 | INK JET INK, INK SET, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT AND INK JET RECORDING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2009-11-05 | — | — | US | disclosed |
| US-20090238975-A1 | INK JET INK, INK JET RECORDING METHOD, INK CARTRIDGE, RECORDING UNIT AND INK JET RECORDING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2009-09-24 | — | — | US | disclosed |
| US-20070043095-A1 | Derivatives of 2-arylimino-2,3-dihydrothiazoles, their preparation processes and their therapeutic use | IPSEN PHARMA S.A.S. (FR) | 2007-02-22 | — | — | US | disclosed |
| EP-0634524-B1 | Paper coating composition | SUMITOMO CHEMICAL CO (JP) | 1999-01-13 | — | — | EP | disclosed |
| US-5654359-A | INK RECEPTIVITY; WATERPROOFING | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1997-08-05 | — | — | US | disclosed |
| EP-0634524-A1 | Paper coating composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-01-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070043095-A1 | Derivatives of 2-arylimino-2,3-dihydrothiazoles, their preparation processes and their therapeutic use | SSTR2, SSTR5, SSTR3 | SIGMAR1 216/4885ADH1B 1511/4885ADH1C 875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.